Telehealth Giant Hims Wants to Test Every Dude for Low Testosterone

The company plans to offer testosterone replacement therapy, marking its first foray into prescribing controlled substances. Talk of testosterone deficiency is hard to escape these days, with podcasters and politicians obsessing over how to avoid a "low T" lifestyle. As the hormone's cultural salience deepens, demand is growing. In a timely move, telehealth giant Hims just launched a testosterone replacement therapy service for cisgender men. The direct-to-consumer juggernaut will offer two types of injectable treatments, as well as an oral pill option that can be sent to patients after they take an at-home capillary blood test.